bioRxiv Science⌕ Search

Biology subjects

Amrita, A.

Publications and source records attributed to Amrita, A..

2 recordsLinked to original sources

Comparative study of manganese catalase monomers, interfaces and cage architecture within the ferritin superfamily

Manganese catalase protein is an example of a protein cage within the ferritin superfamily that focuses on enzymatic catalysis rather than on storage which other ferritin proteins are known for. Formed of 6 homomeric chains, it shows large subunit-subunit sidewise contacts and special interfacial interactions ensuring cage generation with only 6 subunits. We aim to explore manganese catalase at the monomer, subunit-subunit and cage level. As compared to other ferritin subtypes, we found manganese catalase monomers to have greater fraction of {beta}-turns at the secondary structure level and thermophilic manganese catalase monomers to have greater non-polar to polar residue ratio. At the interface level, the placement of subunits in manganese catalase cage with sidewise and angular interface was found to be distinctly different from the parallel and perpendicular interfaces present in other ferritin subtypes. Our study highlights the contribution of sidewise interfaces and terminal extensions in making the cage architecture possible in 6-mer manganese catalases. We also studied the quaternary structure of manganese catalase cage with respect to Classical ferritin (C-ferritin) and found manganese catalase to have smaller cavity volume and cavity surface area than C-ferritin but higher cavity surface to volume ratio. This observation along with the smaller distance between substrate entry point and active site as compared to C-ferritin highlights the structural distinction between catalytic enzymes like manganese catalase and storage proteins like ferritins. Thus, the study gives structural insight into manganese catalase protein cage with focus on its ability to form a cage architecture and show efficient catalytic activity.

bioinformatics↗

Delayed forebrain excitatory and inhibitory neurogenesis inSTRADA-related megalencephaly via mTOR hyperactivity

Biallelic pathogenic variants in STRADA, an upstream regulator of the mechanistic target of rapamycin (mTOR) pathway, result in megalencephaly, drug-resistant epilepsy, and severe intellectual disability. This study explores how mTOR pathway hyperactivity alters cell fate specification in dorsal and ventral forebrain development using STRADA knock-out human stem cell derived brain organoids. In both dorsal and ventral forebrain STRADA knock-out organoids, neurogenesis is delayed, with a predilection for progenitor renewal and proliferation and an increase in outer radial glia. Ventrally, interneuron subtypes shift to an increase in neuropeptide-Y expressing cells. Inhibition of the mTOR pathway with rapamycin results in rescue for most phenotypes. When mTOR pathway variants are present in all cells of the developing brain, overproduction of interneurons and altered interneuron cell fate may underlie mechanisms of megalencephaly, epilepsy, and cognitive impairment. Our findings suggest mTOR inhibition during fetal brain development as a potential therapeutic strategy in STRADA deficiency.

neuroscience↗